"Le Centre Hospitalier Universitaire de la Guadeloupe (CHUG) est le pilier sanitaire de l'archipel. Il assure les missions de soins, de prévention, d'enseignement et de recherche confiées par l'État. Au-delà de ces missions, il joue un rôle prépondérant d’hôpital de proximité pour son bassin de population et participe à des actions de santé publique (éducation pour la santé et prévention). Le CHUG est composé de 8 pôles médicaux regroupant 44 services répartis sur 3 sites : - Le centre hospitalier principal appelé nouveau centre (NCH) ou hôpital général - L’hôpital Joseph Ricou appelé ancien hôpital - Le site de Palais-Royal qui accueil le Pôle Parents-Enfants (PPE) et le Pôle Évaluation Réadaptation et Suivi des Incapacités (ERSI)."

During the past decade, University Hospital of Guadeloupe conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Guadeloupe" #1 collaborator was "University Hospital of Guadeloupe" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de la Réunion" with 1 trials as a collaborator, "Centre Hospitalier de Cayenne" with 1 trials as a collaborator and "Hôpital de Mayotte" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Guadeloupe" are "HIV Infections" (1 trials), "Mild Leptospirosis" (1 trials) and "Zika Virus Infection" (1 trials). Many other conditions were trialed in "University Hospital of Guadeloupe" in a lesser frequency.

Most popular intervention types in "University Hospital of Guadeloupe" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3 days of antibiotherapy" (1 trials) and "Biological sample collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Guadeloupe" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital of Guadeloupe". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Hospital of Guadeloupe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Guadeloupe, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".